The global interventional oncology devices market size is expected to grow from $1.97 billion in 2021 to $2.15 billion in 2022 at a compound annual growth rate (CAGR) of 9.4%. The global interventional oncology device market is expected to grow to $3.03 billion in 2026 at a CAGR of 8.9%.
What is the Global Interventional Oncology Devices Market?
The market for interventional oncology devices comprises the sale of interventional oncology devices and related services by the entities that manufacture them. Interventional oncology devices are used to detect and treat cancer using minimally invasive procedures and advanced imaging technologies.
Get a Sample of the global interventional oncology devices market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&&type=smp
What drives the Global Interventional Oncology Devices Market?
The availability of private and government funding drove the interventional oncology devices market. In the field of cancer, funding from the government and private has increased, especially for the devices used in treatments as it promotes early detection and better survival rates. BioProtect Ltd, an Israeli company that develops novel bioabsorbable polymer spacer balloons, received a funding of $13 million of its Series D equity financing from a leading global syndicate of venture investors that finances the ongoing multicenter FDA clinical trial of BioProtect's lead product, the ProSpace balloon spacer, which protects prostate cancer patients undergoing radiation therapy. Endosight, the first augmented-reality-guided ablative system, has received 20% of its funding from private organizations. The funding from government and private organizations helps in the development of new technologies and devices, thereby driving the interventional oncology devices market.
Get the full global interventional oncology devices industry report here
https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report
Global Interventional Oncology Devices Market Segments
The global interventional oncology devices market is segmented:
By Product: Embolization Devices, Ablation Devices, Support Devices
By Procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE) or Bland Embolization
By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Others
By Geography: The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Interventional Oncology Devices Global Market Report 2022provides market size and growth forecasts for the global interventional oncology devices market, global interventional oncology devices market share, interventional oncology devices market segments and geographies, interventional oncology devices market competitive landscape including leading competitors’ revenues, profiles and market shares. The interventional oncology devices market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Interventional Oncology Devices Industry Playersinclude Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Merit Medical Systems Inc, Philips Volcano, AngioDynamics Inc, GE Healthcare, Siemens Healthineers, Sirtex Medical, and Cook Medical Incorporated. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
